Prokidney (PROK) Interest Coverage Ratio (QoQ) (2022 - 2026)
Powered by 
Analysis
Prokidney (PROK) Interest Coverage Ratio (QoQ) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,514.84% |
| Mar 31, 2026 | 93.40% |
| Dec 31, 2025 | -135.45% |
| Sep 30, 2025 | 51.47% |
| Dec 31, 2024 | -5.30% |
| Sep 30, 2024 | -70.61% |
| Jun 30, 2024 | 28.38% |
| Mar 31, 2024 | -148.30% |
| Dec 31, 2023 | 65.38% |
| Sep 30, 2023 | -134.14% |
| Jun 30, 2023 | 26.94% |
| Mar 31, 2023 | 9.87% |
| Dec 31, 2022 | -1,132.45% |
| Sep 30, 2022 | -905.52% |
| Jun 30, 2022 | 97.43% |